ALX Oncology Holdings Inc. (ALXO) Misses Q2 EPS by 6c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q2 EPS of ($0.49), $0.06 worse than the analyst estimate of ($0.43).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Northrop Grumman wins two U.S. defense contracts worth $38.7m
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance